Colorado Press Releases

May 8, 2024

Cancer Advocates Commend Colorado Lawmakers for Positive First Step in Opening Door to Precision Medicine

The American Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now complete, the bill now awaits the signature of Governor Jared Polis. If enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing. 

March 13, 2024

Cancer Advocates Urge Colorado Legislators to Take Critical Step to Connect Patients with Most Effective Treatment Options

DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure  biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.

March 8, 2023

Cancer Survivors to Governor, Legislators: Expand Access to Biomarker Testing in Colorado

The American Cancer Society Cancer Action Network (ACS CAN) hosted ‘Cancer Action Day’ at the Colorado state capitol Wednesday. ACS CAN volunteers, including cancer survivors, patients, and caregivers met with several lawmakers and urged them to support and pass House Bill 1110, Healthcare Coverage for Biomarkers Testing. The bi-partisan legislation would expand equitable access to biomarker testing statewide. 

March 1, 2022

Colorado Cancer Advocates, U.S. Senator Bennet Call on Congress to Enact Policy to Create a Pathway to Coverage for Innovative Multi-Cancer Screenings for Millions

A virtual event held by ACS CAN and U.S. Sen. Michael Bennet highlighted the promise of new blood-based cancer screening technologies that have the potential to dramatically increase early-stage diagnosis for a wide range of cancers and called on Congress to pass the Multi-Cancer Early Detection Screening Coverage (MCED) Act.